OSAIC HOLDINGS, INC.

Position in GANX — Gain Therapeutics, Inc.

CIK 1677044 SCOTTSDALE, AZ

Position in GANX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,060

-$28,590 QoQ

Shares Held

2,000

-80.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#44

of 49 holders

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

OSAIC HOLDINGS, INC. holds $237,724,860 across 405 Biotechnology names. GANX ranks #251 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	90,236	$28,522,697
2	VRTX	Vertex Pharmaceuticals Inc / Ma	49,586	$24,630,851
3	TGTX	Tg Therapeutics, Inc.	372,588	$20,469,983
4	BBIO	BridgeBio Pharma, Inc.	217,577	$16,205,134
5	HALO	Halozyme Therapeutics, Inc.	176,973	$13,851,674
6	ALNY	Alnylam Pharmaceuticals, Inc.	45,298	$13,636,055
7	VCEL	Vericel Corp	182,038	$8,098,869
8	REGN	Regeneron Pharmaceuticals, Inc.	12,423	$7,746,234

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,060	2,000	-80.0%	Shares	Defined	2026-08-14
2023-12-31	$32,650	10,000	0.0%	Shares	Defined	2024-02-12
2023-09-30	$32,800	10,000	0.0%	Shares	Defined	2023-11-13
2023-06-30	$44,800	10,000	0.0%	Shares	Defined	2023-08-21
2023-03-31	$48,200	10,000	0.0%	Shares	Defined	2023-05-12
2022-12-31	$31,300	10,000	0.0%	Shares	Defined	2023-02-10
2022-09-30	$32,600	10,000	-1.0%	Shares	Defined	2022-11-14
2022-06-30	$36,360	10,100	+0.5%	Shares	Defined	2022-08-10
2022-03-31	$41,104	10,050	0.0%	Shares	Defined	2022-05-04
2021-12-31	$54,571	10,050	—	Shares	Defined	2022-02-03
No filing history on record for this holder in this stock.